Latest clinical trials News | Page 39

Major discovery provides new hope for blood cancer patients
TGA grants provisional approval to Gilead Sciences Pty Ltd to extend use of Covid treatment, VEKLURY
Enhertu approved in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based regimen
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
New senior appointments for Tessara Therapeutics
Digital health support systems help improve health for people with breast cancer
USC clinical trial of potential new influenza vaccine
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Govt and Air New Zealand to trial innovative and accurate new Covid test
Government subsidy accelerates new era in prostate cancer treatment
Understanding experience of female IRD carriers
Clinical trial of potential vaccine for cytomegalovirus
‘Very optimistic’: Research offers hope for MND and Alzheimer’s gene treatment
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Millions worldwide could benefit after breakthrough trial in treatment for Alzheimer’s
New UK-based business development for Adherium
First targeted treatment for aggressive breast cancer disproportionately affecting younger people funded by Government
Three pillars of malaria elimination
ANU random numbers go global
Over 1 million African children protected by first malaria vaccine
Clinical trial to test psychedelics in treating depression
New production method promises to end medical radioisotope shortages
Does psychedelic science need philosophy?
Promising drug candidates for Crimean-Congo haemorrhagic fever identified
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Zelria Therapeutics executes acquisition of Health House
Signaling pathway in immune cells could be Alzheimer’s target
Monash No.1 World Rank Confirms Victorian Excellence
New $750 million hospital in heart of Mallee
CRISPR gene editing reveals biological mechanism behind common blood disorder
University of Toronto partners with Moderna to advance research in RNA science and technology
Broadening and scaling reach of mRNA vaccines
Race receives human ethics approval for new trial
MTPConnect announces support for major new resilience projects
Novel acute myeloid leukemia subtypes identified
International partnership may hold key to new cancer therapies
Female hormones could provide clues to higher risk of dementia in women
Our CEO shares his cancer story
Microba announces new research partnership and senior appointment
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Monash launches flagship biological storage facility: Biobanking Victoria
Monash awarded $23M federal funding as part of $71M Australian Precision Medicine Enterprise project
Locally made medicines
Victorian Biobank Now Globally Recognised
Greater awareness of key bowel cancer risk factors needed, new research finds
New hope for Australians affected by pancreatic cancer
Researchers Outline Bias in Epidemic Research-And Offer New Simulation Tool to Guide Future Work